Search Stock News and Analysis

Dow Futures Higher Ahead of Fed Decision

https://www.schaeffersresearch.com/content/ezines/2019/10/30/dow-futures-higher-ahead-of-fed-decision

10/30/2019 9:14 AM

U.S stock futures are pointing to a higher open ahead of a huge day on Wall Street. Investors are gearing up for the Fed's rate-cut decision this afternoon, and the subsequent press conference from...

Biogen Bombshell Triggers Annual-High Options Volume

https://www.schaeffersresearch.com/content/options/2019/10/22/biogen-bombshell-triggers-annual-high-options-volume

10/22/2019 12:58 PM

The shares of Biogen Inc (NASDAQ:BIIB) have skyrocketed today, after the company surprised investors with plans to submit its Alzheimer's treatment for regulatory approval in the U.S. Biogen disconti...

Spinraza Worries Spark Bear Note for Biogen

https://www.schaeffersresearch.com/content/news/2019/10/17/spinraza-worries-spark-bear-note-for-biogen

10/17/2019 9:49 AM

BofA-Merrill Lynch resumed coverage on Biogen Inc (NASDAQ:BIIB) with an "underperform" rating and a $200 price target -- a more than 12% discount to last night's close. The brokerage firm cited incre...

Trade-Sensitive Stocks Set the Tone for Short July 4th Trading Week

https://www.schaeffersresearch.com/content/news/2019/07/05/trade-sensitive-stocks-set-the-tone-for-short-july-4th-trading-week

7/5/2019 3:06 PM

It was a solid week for stocks, with the Fourth of July holiday offering an abbreviated start to the new month. The Dow, S&P 500, and Nasdaq used early-week trade truce momentum to nab weekly wins,...

BIIB Stock Gets Boost on Promising Drug Data

https://www.schaeffersresearch.com/content/news/2019/07/01/biib-stock-gets-boost-on-promising-drug-data

7/1/2019 10:23 AM

The shares of Biogen Inc (NASDAQ:BIIB) are up 0.9% at $236 after the firm said its spinal muscular atrophy treatment Spinraza was well tolerated in patients with the disease, with many seeing "unprec...

PEOPLE ALSO SEARCH FOR